Real-time enrollment status for this myasthenia gravis, generalized clinical trial
Current Status
Recruiting
Checked: July 13, 2026 at 7:38 AM UTC
| NCT Number | NCT07501702 |
| Recruiting Status | Recruiting |
| Condition | Myasthenia Gravis, Generalized |
| Phase | Clinical Trial |
| Target Enrollment | 30 participants |
| Active Locations | 13 sites in the US |
| Sponsor | Vertex Pharmaceuticals Incorporated |
| Last Updated on CT.gov | June 29, 2026 (2 weeks ago) |
As of July 13, 2026: Clinical trial NCT07501702 is currently recruiting participants. This clinical trial study for myasthenia gravis, generalized is actively seeking new participants at 13 locations across the United States. The study is sponsored by Vertex Pharmaceuticals Incorporated. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07501702 is actively recruiting participants as of July 13, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 13 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07501702 was last updated 2 weeks ago (June 29, 2026). HelloStudys verifies this status automatically.